Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism. [electronic resource]
Producer: 20130628Description: 1697-708 p. digitalISSN:- 1939-327X
- AMP-Activated Protein Kinases -- metabolism
- Animals
- Cardiotonic Agents -- therapeutic use
- Cells, Cultured
- Cyclic AMP -- metabolism
- Diabetic Angiopathies -- metabolism
- Diabetic Cardiomyopathies -- metabolism
- Disease Models, Animal
- Endothelium, Vascular -- cytology
- Exenatide
- Glucagon-Like Peptide 1 -- analogs & derivatives
- Heart Ventricles -- drug effects
- Hyperglycemia -- blood
- Hypoglycemic Agents -- therapeutic use
- Male
- Microvessels -- drug effects
- Oxidative Stress -- drug effects
- Peptides -- therapeutic use
- Random Allocation
- Rats
- Rats, Sprague-Dawley
- Second Messenger Systems -- drug effects
- Venoms -- therapeutic use
- rho GTP-Binding Proteins -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.